News Coverage 10.22.19 By: Molika Ashford Share on Twitter Share on Facebook Share on LinkedIn Q&A: The Parker Institute’s Theresa LaVallee on the Path Forward for Precision Immuno-Oncology Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial